NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Investing.com - Oppenheimer has reiterated an Outperform rating and $20.00 price target on Q32 Bio Inc. (NASDAQ:QTTB), following competitor Nektar Therapeutics ’ recent clinical trial results in ...

The biological world is always expanding as research is constantly being done. Because of this, many findings often fall under the radar despite having the potential to change the world. Here are some ...

Jeff Bezos has had quite a hectic week, having just concluded his third venture capital investment in a promising artificial intelligence startup. This time, the recipient of Bezos’s largesse is a ...

A new claim from an analyst with an extremely limited track record says that Apple will mark the 20th anniversary of the iPhone with an iPhone 20 that launches in the first half of 2027. It's long ...

Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...

Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its ambitious slogan, “Edit the message. Rewrite the future,” or from its corporate strategy, which the developer ...

PHILADELPHIA, July 10, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (“Passage Bio” or the “Company”) (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients ...

The iPhone 20, expected to debut in 2027, is shaping up to be a defining moment in Apple’s history. As the 20th-anniversary edition of the iPhone, it is rumored to introduce a combination of ...

Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers. Parataxis Holdings, an affiliate of ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min BlueSphere Bio's new chief ...